Pylopass L.Reuteri DSM17648 120’s

Description

Pylopass contains patented strain L. reuteri DSM 17648, designed to target specific stomach bacteria. The strain has been put through 5 clinical trials to prove its safety and effectiveness. Each capsule delivers 5 billion CFU of the L. reuteri strain and is acid resistant.